dc.contributor.author | Executive Board, 126 | |
dc.coverage.spatial | Geneva | en |
dc.date.accessioned | 2011-11-11T13:18:33Z | |
dc.date.available | 2011-11-11T13:18:33Z | |
dc.date.issued | 2010 | |
dc.identifier.govdoc | EB126/6 | |
dc.identifier.uri | https://iris.who.int/handle/10665/2289 | |
dc.description | Executive Board 126th session, provisional agenda item 4.3 | en |
dc.language.iso | en | en |
dc.publisher | World Health Organization | en |
dc.subject | Intellectual property | en |
dc.subject | Research | en |
dc.subject.mesh | Intellectual Property | en |
dc.subject.mesh | Research | en |
dc.subject.mesh | Pharmaceutical Preparations | en |
dc.subject.mesh | Influenza Vaccines | en |
dc.subject.mesh | Biomedical Technology | en |
dc.subject.mesh | Tropical Medicine | en |
dc.subject.mesh | Interinstitutional Relations | en |
dc.title | Public health, innovation and intellectual property: global strategy and plan of action: report by the Secretariat | en |
dc.type | Governing body documents | en |
dc.subject.meshqualifier | standards | en |
who.relation.languageVersion | 10665/3659 | en |
who.relation.languageVersion | 10665/2633 | en |
who.relation.languageVersion | 10665/4471 | en |
who.relation.languageVersion | 10665/3982 | en |
who.relation.languageVersion | 10665/2710 | en |